We have to remember what the market is. It is appetite before digestion of a meal. A market that has already seen that appetite rise to 200m mc, will know that it did so, because that registry was captured with the idea of what this could deliver into a paradigm change in medical diagnosis conga line. The prize, is what ultimately attracts punters.
If the prize was measured in a potential of forward earnings from the printer ink model entering both MRI and MRX to doctors office, it had orbital implications. When standard of care is shifted globally, and the vehicle you invest in, is providing the magic juice to make it happen. In the scheme of things, the covid delays, and inept management boy scout ethics on patient recruitment, delayed, not derailed this train.
We are further de-risked, having MRI contrast review, and phase 1 safety and bio kinetics as expected.
The market is gambling. It is a casino. The lure of the prize remains the same, but what happens is that the payout odds shift, as buyers are forced to pay a higher entry cost, when the low hanging fruit runs out. The winning payout can remain elusive, but the movement in the odds spread that we see in the sp volatility is still potential to play the hand and free carry any risk.
Just saying, if we learn of history, there is proven appetite for this vehicle and where it is headed. And that will lure new passengers to replace the weary. And to replicate any free carry x 2, i am buying when this is at the pointy end, before the news flow starts into the US phase 2.
